Endocannabinoid signaling in female reproductive events: A potential therapeutic target?

Expert Opinion on Therapeutic Targets

Volumn 19, Issue 11, 2015, Pages 1423-1427

  Maccarrone, Mauro ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

immune regulation; implantation; oocyte maturation; oviductal transport; parturition; signaling pathways

Indexed keywords

ENDOCANNABINOID;

FEMALE; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; GENE EXPRESSION; HUMAN; OOCYTE DEVELOPMENT; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; INFERTILITY, FEMALE; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCTION;

ENDOCANNABINOIDS; FEMALE; HUMANS; INFERTILITY, FEMALE; MOLECULAR TARGETED THERAPY; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 84946723237     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2015.1062878     Document Type: Review

References (20)

1. Fezza F, Bari M, Florio R, et al. Endocannabinoids, related compounds and their metabolic routes. Molecules 2014;19(11):17078-106
2. Rahman IA, Tsuboi K, Uyama T, Ueda N. New players in the fatty acyl ethanolamide metabolism. Pharmacol Res 2014;86(1):1-10
3. Rapino C, Battista N, Bari M, Maccarrone M. Endocannabinoids as biomarkers of human reproduction. Hum Rep Update 2014;20(4):501-16
4. Wang H, Dey SK, Maccarrone M. Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility. Endo Rev 2006;27(5):427-48
5. Maccarrone M. Endocannabinoids: friends and foes of reproduction. Prog Lipid Res 2009;48(6):344-54
6. Karasu T, Marczylo TH, Maccarrone M, Konje JC. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility. Hum Rep Update 2011;17(3):347-61
7. Sun X, Dey SK. Endocannabinoid signaling in female reproduction. ACS Chem Neurosci 2012;3(5):349-55
8. Stulberg DB, Cain LR, Dahlquist I, Lauderdale DS. Ectopic pregnancy rates and racial disparities in the Medicaid population, 2004-2008. Fertil Steril 2014;102(6):1671-6
9. Maccarrone M, Valensise H, Bari M, et al. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 2000;355(9212):1326-9
10. Habayeb OM, Taylor AH, Finney M, et al. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA 2008;299(10):1135-6
11. Maccarrone M, Bisogno T, Valensise H, et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod 2002;8(2):188-95
12. Sun X, Cappelletti M, Li Y, et al. Cnr2 deficiency confers resistance to inflammation-induced preterm birth in mice. Endocrinology 2014;155(10):4006-14
13. El-Talatini MR, Taylor AH, Elson JC, et al. Localisation and function of the endocannabinoid system in the human ovary. PLoS One 2009;4(2):e4579
14. Xie H, Sun X, Piao Y, et al. Silencing or amplification of endocannabinoid signaling in blastocysts via CB1 compromises trophoblast cell migration. J Biol Chem 2012;287(38):32288-97
15. Bisogno T, Maccarrone M. Latest advances in the discovery of fatty acid amide hydrolase inhibitors. Expert Opin Drug Discov 2013;8(5):509-22
16. Scott SA, Spencer CT, O'Reilly MC, et al. Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes. ACS Chem Biol 2015;10(2):421-32
17. Beltrame JS, Sordelli MS, Cella M, et al. Lysophosphatidic acid increases the production of pivotal mediators of decidualization and vascularization in the rat uterus. Placenta 2013;34(9):751-6
18. Maccarrone M, Dainese E, Oddi S. Intracellular trafficking of anandamide: new concepts for signaling. Trends Biochem Sci 2010;35(11):601-8
19. Yu S, Levi L, Casadesus G, et al. Fatty acid binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferatoractivated receptor b/d (PPARb/d) in the brain. J Biol Chem 2014;289(18):12748-58
20. Keppel Hesselink JM, Kopsky DJ, Sajben NL. Vulvodynia and proctodynia treated with topical baclofen 5% and palmitoylethanolamide. Arch Gynecol Obstet 2014;290(2):389-93